Histogen Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Histogen Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2023.
Histogen Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$3.53M, a 2.03% increase year-over-year.
Histogen Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$12.1M, a 11.5% decline year-over-year.
Histogen Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 31.1% increase from 2021.
Histogen Inc. annual Operating Income (Loss) for 2021 was -$15.5M, a 18% increase from 2020.
Histogen Inc. annual Operating Income (Loss) for 2020 was -$18.9M, a 468% decline from 2019.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	-$12.1M	-$3.53M	+$73K	+2.03%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$12.1M	-$2.09M	+$1.31M	+38.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	-$13.4M	-$3.47M	-$2.79M	-409%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	-$10.6M	-$2.97M	+$166K	+5.3%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-09
Q3 2022	-$10.8M	-$3.6M	+$259K	+6.72%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$11.1M	-$3.39M	+$799K	+19.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$11.9M	-$683K	+$3.59M	+84%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	-$15.5M	-$3.13M	+$374K	+10.7%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	-$15.8M	-$3.86M	-$511K	-15.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021	-$15.3M	-$4.19M	+$5.96M	+58.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$21.3M	-$4.27M	-$2.42M	-130%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$18.9M	-$3.51M	-$10.8M	-148%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-10
Q3 2020	-$8.02M	-$3.35M	-$1.6M	-91.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$6.42M	-$10.2M	-$6.2M	-157%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11
Q1 2020	-$223K	-$1.85M	+$3.1M	+62.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	-$3.32M	$7.33M	+$11.3M		Oct 1, 2019	Dec 31, 2019	10-K	2021-03-11
Q3 2019	-$14.7M	-$1.75M	+$2.91M	+62.5%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019	-$17.6M	-$3.95M	+$608K	+13.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$18.2M	-$4.95M	+$107K	+2.12%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	-$18.3M	-$4.01M	+$402K	+9.12%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-11
Q3 2018	-$18.7M	-$4.66M	-$610K	-15.1%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	-$18.1M	-$4.56M	+$847K	+15.7%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	-$18.9M	-$5.06M	-$1.37M	-37%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-03
Q4 2017	-$17.6M	-$4.41M	+$4.77M	+52%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-11
Q3 2017	-$22.3M	-$4.05M	+$2.85M	+41.3%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-01
Q2 2017	-$25.2M	-$5.4M	+$1.08M	+16.7%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-02
Q1 2017	-$26.2M	-$3.69M	+$3.58M	+49.3%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-03
Q4 2016	-$29.8M	-$9.18M			Oct 1, 2016	Dec 31, 2016	10-K	2019-03-08
Q3 2016		-$6.89M			Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-02
Q2 2016		-$6.48M			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-04
Q1 2016		-$7.27M			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-05

* An asterisk sign (*) next to the value indicates that the value is likely invalid.